Impact of clinicopathological characteristics on the efficacy of neoadjuvant therapy in patients with human epidermal growth factor receptor-2-positive breast cancer-Reference-Cited by-同舟云学术

Impact of clinicopathological characteristics on the efficacy of neoadjuvant therapy in patients with human epidermal growth factor receptor-2-positive breast cancer

Published:2017-10-25 Issue:4 Volume:142 Page:844-853
ISSN:0020-7136
Container-title:International Journal of Cancer
language:en
Short-container-title:Int. J. Cancer

Author:

Zhao Bin¹^ORCID,Zhao Hong²

Affiliation:

1. The Second Affiliated Hospital & Yuying Children's Hospital, Wenzhou Medical University; Wenzhou China

2. Department of Medical Oncology; The Third Affiliated Hospital of Harbin Medical University; Harbin China

Funder

National Natural Science Foundation of China

Natural Science Foundation of Heilongjiang Province

Haiyan Foundation of the Third Affiliated Hospital of Harbin Medical University

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference39 articles.

1. Global cancer statistics;Jemal;Ca Cancer J Clin,2011

2. Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene;Slamon;Science,1987

3. Efficacy of adjuvant trastuzumab for patients with human epidermal growth factor receptor 2-positive early breast cancer and tumors = 2 cm: a meta-analysis of the randomized trastuzumab trials;O'Sullivan;J Clin Oncol,2015

4. Neoadjuvant therapy for breast cancer;Zardavas;Annu Rev Med,2015

5. Pathological complete response and accelerated drug approval in early breast cancer;Prowell;N Engl J Med,2012

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Axillary Downstaging and the Impact of Clinical Axillary Status on Efficacy of Neoadjuvant Therapy for HER2-Positive Breast Cancer: A Network Meta-Analysis;Technology in Cancer Research & Treatment;2023-01

2. Early prediction of treatment response to neoadjuvant chemotherapy based on longitudinal ultrasound images of HER2-positive breast cancer patients by Siamese multi-task network: A multicentre, retrospective cohort study;eClinicalMedicine;2022-10

3. Comparison of the efficacy and safety of first-line treatments based on clinicopathological characteristics for patients with advanced epidermal growth factor receptor mutated non-small-cell lung cancer: A systematic review and network meta-analysis;Critical Reviews in Oncology/Hematology;2022-09

4. Comparing Biomarkers for Predicting Pathological Responses to Neoadjuvant Therapy in HER2-Positive Breast Cancer: A Systematic Review and Meta-Analysis;Frontiers in Oncology;2021-10-28

5. Efficacy and safety profile of avelumab monotherapy;Critical Reviews in Oncology/Hematology;2021-10